We are live on ! Find out more
Boxer Capital

Boxer Capital Portfolio holdings

AUM $2.04B Turnover 20.83%
1-Year Est. Return 108.39%
This Fund
S&P 500
This Quarter Est. Return
+54.07%
1 Year Est. Return
+108.39%
3 Year Est. Return
+261.8%
5 Year Est. Return
+1,135.1%
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$110M
Cap. Flow
+$42.4M
Cap. Flow %
18.99%
Top 10 Hldgs %
78.3%
Holding
30
New
7
Increased
5
Reduced
4
Closed
2
Avg Time Held Equity + Options
0.4 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.5 years

Sector Composition

Rank Sector Weight
1 Healthcare 87.73%
2 Miscellaneous 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLVS
1
DELISTED
Clovis Oncology
CLVS
$36M 16.16%
1,000,000
+550,000
+122% +$11.8M
2016 Q2
1 quarter
MDCO
2
DELISTED
Medicines Co
MDCO
$26.4M 11.84%
+700,000
New +$26.4M
2016 Q3
0 quarters
BPMC icon
3
DELISTED
Blueprint Medicines
BPMC
$20.9M 9.39%
705,159
– –
2015 Q4
3 quarters
MDCO
4
CALL
DELISTED
Medicines Co
MDCO
$20.7M 9.3%
+549,800
New +$20.7M
2016 Q3
0 quarters
ONC icon
5
BeOne Medicines
ONC
$45.7B
$15.2M 6.82%
493,630
– –
2016 Q1
2 quarters
SGEN
6
DELISTED
Seagen
SGEN
$12.6M 5.63%
232,600
– –
2015 Q4
3 quarters
AVXS
7
DELISTED
AveXis
AVXS
$12.4M 5.54%
299,756
+157,092
+110% +$5.97M
2016 Q1
2 quarters
NGNE icon
8
Neurogene
NGNE
$475M
$11.7M 5.26%
43,888
– –
2015 Q4
3 quarters
INCY icon
9
Incyte
INCY
$23.6B
$9.43M 4.23%
100,000
– –
2016 Q1
2 quarters
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.9B
$9.25M 4.15%
100,000
+30,000
+43% +$2.82M
2016 Q1
2 quarters
ARDM
11
DELISTED
Aradigm
ARDM
$6.4M 2.87%
930,513
-171,000
-16% -$832K
2015 Q4
3 quarters
MRTX
12
DELISTED
Mirati Therapeutics
MRTX
$5.01M 2.25%
757,935
– –
2015 Q4
3 quarters
RIGL icon
13
Rigel Pharmaceuticals
RIGL
$776M
$4.96M 2.22%
135,114
+65,114
+93% +$1.87M
2016 Q2
1 quarter
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$822M
$3.55M 1.59%
234,220
– –
2016 Q1
2 quarters
TSRO
15
DELISTED
Tesaro
TSRO
$3.51M 1.57%
35,000
-40,000
-53% -$3.74M
2016 Q2
1 quarter
HRTX icon
16
Heron Therapeutics
HRTX
$50.3M
$3.45M 1.54%
+200,000
New +$3.71M
2016 Q3
0 quarters
KURA icon
17
Kura Oncology
KURA
$675M
$3.33M 1.49%
533,251
-100,441
-16% -$509K
2015 Q4
3 quarters
ALDX icon
18
Aldeyra Therapeutics
ALDX
$43.6M
$2.29M 1.02%
291,230
– –
2015 Q4
3 quarters
CARM icon
19
DELISTED
Carisma Therapeutics
CARM
$2.1M 0.94%
37,500
-12,500
-25% -$931K
2016 Q2
1 quarter
EIGR
20
DELISTED
Eiger BioPharmaceuticals
EIGR
$1.85M 0.83%
4,611
+1,500
+48% +$765K
2015 Q4
3 quarters
ARRY icon
21
DELISTED
Array Biopharma
ARRY
$1.35M 0.61%
+200,000
New +$774K
2016 Q3
0 quarters
NBRV
22
DELISTED
Nabriva Therapeutics
NBRV
$1.25M 0.56%
707
– –
2015 Q4
3 quarters
AKTX icon
23
Akari Therapeutics
AKTX
$15.3M
$1.19M 0.53%
175
– –
2015 Q4
3 quarters
TRAW icon
24
Traws Pharma
TRAW
$3.53M
$838K 0.38%
+56
New +$1.14M
2016 Q3
0 quarters
NVET
25
DELISTED
Nexvet Biopharma
NVET
$643K 0.29%
154,840
– –
2015 Q4
3 quarters

Similar funds

Boxer Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Boxer Capital held 30 positions worth $223M, up 98% from $113M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Boxer Capital deployed $42.4M of net new capital in Q3 2016, opening 7 new positions and adding to 5 existing holdings. Its largest new stake was Medicines Co: 700,000 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was Tesaro, an estimated $3.74M trimmed.

  • Boxer Capital's largest Q3 2016 buy was Medicines Co: 700,000 shares worth $26.4M.
  • Boxer Capital added most to Clovis Oncology in Q3 2016, an estimated $11.8M increase.
  • Boxer Capital's biggest Q3 2016 reduction was Tesaro, cutting an estimated $3.74M.
  • Boxer Capital fully exited Regeneron Pharmaceuticals in Q3 2016, selling an estimated $6.98M.
  • Boxer Capital's ten largest holdings make up 78% of its $223M portfolio in Q3 2016.
  • Boxer Capital opened 7 new positions and closed 2 in Q3 2016.
  • Boxer Capital's portfolio value rose 98% quarter-over-quarter to $223M.

Based on Boxer Capital's 13F filing for Q3 2016, filed 14 Nov 2016.